Sleisenger & Fordtran's Gastrointestinal and Liver Disease

Featured advances discussed in the 11th edition include improved diagnosis and treatment of chronic hepatitis B and C; evolution in the diagnosis and treatment of Helicobacter pylori infection and the resulting benefits on the prevention and treatment of peptic ulcer disease and gastric neoplasia; improvements in the prevention of colorectal cancer through screening and surveillance; new approaches to the recognition and treatment of Barrett esophagus and consequent prevention of esophageal adenocarcinoma; the expanding use of biologic agents and novel small molecules to treat and prevent recurrences of IBD.